PATENT CLAIM ANALYSIS

Application Number: 15967260
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "018100"]

Abstract:
Aspects of the present invention include treating a subject having an acute of chronic central nervous system disorder, such as a brain disorder or spinal cord disorder, by administering an agent that inhibits TREM1 activity and/or expression.

Claim (Index 2):
The method of  claim 1 , wherein the TREM1 inhibitory agent inhibits TREM1 signaling activity.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 91.0
- Lexical Diversity: 1.17647
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14780242', '14096414', '15756043', '11718786', '15110004']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6863119812420805
- 35 USC 102 Novelty (BERT): 0.5268290878081245
- Combined Prediction Score: 0.6703636918986849
- Mean Citation Score: 182.241474
- Max Citation Score: 233.71754
- Similarity Product: 123.03397681418656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test